GEMCOVAC®-19
Gennova’s mRNA vaccine, GEMCOVAC®-19, which is stable at 2-8°C,
has received the Emergency Use Authorization (EUA)
Features
India's First mRNA Vaccine
SYNTHETIC & STABLE AT 2-8˚C
India's First mRNA Vaccine
Developed to address the problems in the earlier approved mRNA vaccines.
RAPID DEVELOPMENT
SYNTHETIC & STABLE AT 2-8˚C
India's First mRNA Vaccine
The mRNA development platform has the potential to develop rapidly.
SYNTHETIC & STABLE AT 2-8˚C
SYNTHETIC & STABLE AT 2-8˚C
SYNTHETIC & STABLE AT 2-8˚C
GEMCOVAC® mRNA vaccine is stable at 2–8 °C and can be considered superior in terms of deployability in India and other developing nations (especially LMICs) compared to other approved mRNA vaccines.